The beneficial effect of palliative resection in metastatic colorectal cancer
Authors:
Open Access
- 12 March 2013
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 108 (7) , 1425-1431
Abstract
Background: We aimed to determine the role of palliative resection in metastatic colorectal cancer (mCRC) and ascertain which patient populations would benefit most from this treatment. Methods: A total of 1015 patients diagnosed with mCRC at Seoul National University Hospital between 2000 and 2009 were retrospectively studied. Results: Of the 1015 patients, 168 patients with only liver and/or lung metastasis received curative resection. The remaining 847 patients were treated with palliative chemotherapy and/or palliative resection combined with best supportive care. Palliative resection was performed in 527 (62.2%) cases (complete resection with negative margin (R0) in 93, R1/2 in 434). Resected patients had a more prolonged median overall survival (OS) than unresected patients (21.3 vs 14.1 months; Pvs 19.1 months; Pvs 14.1 months; PP=0.003). Conclusion: Palliative resection without residual disease and chemotherapy confers a longer-term survival outcome than palliative chemotherapy alone in mCRC patient subset.Keywords
This publication has 24 references indexed in Scilit:
- Operative Salvage for Retroperitoneal Nodal Recurrence in Colorectal Cancer: A Systematic ReviewAnnals of Surgical Oncology, 2010
- Adrenalectomy for Clinically Isolated Metastasis from Colorectal Carcinoma: Report of Eight CasesDiseases of the Colon & Rectum, 2008
- EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- The role of cytoreductive surgery for colon cancer metastatic to the ovaryGynecologic Oncology, 2007
- Ovarian metastasis from colorectal cancer: Prognostic value of radical oophorectomyJournal of Surgical Oncology, 2007
- Survival of Patients With Advanced Colorectal Cancer Improves With the Availability of Fluorouracil-Leucovorin, Irinotecan, and Oxaliplatin in the Course of TreatmentJournal of Clinical Oncology, 2004
- Elective Bowel Resection for Incurable Stage IV Colorectal Cancer: Prognostic Variables for Asymptomatic PatientsJournal of the American College of Surgeons, 2003
- Colon Cancer with Metastasis to the Ovary at Time of Initial DiagnosisGynecologic Oncology, 1997
- Operation in patients with incurable colon cancer—Is it worthwhile?Diseases of the Colon & Rectum, 1997
- The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT InvestigatorsJAMA, 1996